These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33395606)

  • 1. Novel N,N-di-alkylnaphthoimidazolium derivative of β-lapachone impaired Trypanosoma cruzi mitochondrial electron transport system.
    Bombaça ACS; Silva LA; Chaves OA; da Silva LS; Barbosa JMC; da Silva AM; Ferreira ABB; Menna-Barreto RFS
    Biomed Pharmacother; 2021 Mar; 135():111186. PubMed ID: 33395606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial disfunction and ROS production are essential for anti-Trypanosoma cruzi activity of β-lapachone-derived naphthoimidazoles.
    Bombaça ACS; Viana PG; Santos ACC; Silva TL; Rodrigues ABM; Guimarães ACR; Goulart MOF; da Silva Júnior EN; Menna-Barreto RFS
    Free Radic Biol Med; 2019 Jan; 130():408-418. PubMed ID: 30445126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Gel Electrophoresis (DIGE) Evaluation of Naphthoimidazoles Mode of Action: A Study in Trypanosoma cruzi Bloodstream Trypomastigotes.
    Brunoro GV; Faça VM; Caminha MA; Ferreira AT; Trugilho M; de Moura KC; Perales J; Valente RH; Menna-Barreto RF
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004951. PubMed ID: 27551855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A proteomic analysis of the mechanism of action of naphthoimidazoles in Trypanosoma cruzi epimastigotes in vitro.
    Menna-Barreto RF; Beghini DG; Ferreira AT; Pinto AV; De Castro SL; Perales J
    J Proteomics; 2010 Nov; 73(12):2306-15. PubMed ID: 20621210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into the pro-oxidant mechanism of dehydroleucodine on Trypanosoma cruzi.
    Gomez J; Coll M; Guarise C; Cifuente D; Masone D; Tello PF; Piñeyro MD; Robello C; Reta G; Sosa MÁ; Barrera P
    Sci Rep; 2024 Aug; 14(1):18875. PubMed ID: 39143185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammea type coumarins isolated from Calophyllum brasiliense induced apoptotic cell death of Trypanosoma cruzi through mitochondrial dysfunction, ROS production and cell cycle alterations.
    Rodríguez-Hernández KD; Martínez I; Reyes-Chilpa R; Espinoza B
    Bioorg Chem; 2020 Jul; 100():103894. PubMed ID: 32388434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trypanosoma cruzi: death phenotypes induced by ortho-naphthoquinone substrates of the aldo-keto reductase (TcAKR). Role of this enzyme in the mechanism of action of β-lapachone.
    Garavaglia PA; Rubio MF; Laverrière M; Tasso LM; Fichera LE; Cannata JJB; García GA
    Parasitology; 2018 Aug; 145(9):1251-1259. PubMed ID: 29400267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into Chagas treatment based on the potential of bacteriocin AS-48.
    Martín-Escolano R; Cebrián R; Martín-Escolano J; Rosales MJ; Maqueda M; Sánchez-Moreno M; Marín C
    Int J Parasitol Drugs Drug Resist; 2019 Aug; 10():1-8. PubMed ID: 30953804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects on Trypanosoma cruzi of novel synthetic naphthoquinones are mediated by mitochondrial dysfunction.
    Menna-Barreto RF; Goncalves RL; Costa EM; Silva RS; Pinto AV; Oliveira MF; de Castro SL
    Free Radic Biol Med; 2009 Sep; 47(5):644-53. PubMed ID: 19501647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The trypanocidal activity of naphthoquinones: a review.
    Pinto AV; de Castro SL
    Molecules; 2009 Nov; 14(11):4570-90. PubMed ID: 19924086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural and synthetic naphthoquinones active against Trypanosoma cruzi: an initial step towards new drugs for Chagas disease.
    Salas CO; Faúndez M; Morello A; Maya JD; Tapia RA
    Curr Med Chem; 2011; 18(1):144-61. PubMed ID: 21110810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The chemotherapy of Chagas disease].
    Stoppani AO
    Medicina (B Aires); 1999; 59 Suppl 2():147-65. PubMed ID: 10668258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of 1,4-Naphthoquinone Hit Compound: A Computational, Phenotypic, and In Vivo Screening against
    Lara LS; Lechuga GC; Moreira CDS; Santos TB; Ferreira VF; da Rocha DR; Pereira MCS
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33467422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of nifurtimox, benznidazole, and beta-lapachone on the metabolism of DNA, RNA and proteins in Trypanosoma cruzi].
    Goijman SG; Stoppani AO
    Rev Argent Microbiol; 1983; 15(4):193-204. PubMed ID: 6086046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of 2-hydroxy-3-phenylsulfanylmethyl-[1,4]-naphthoquinone derivatives against different Trypanosoma cruzi discrete type units: Identification of a promising hit compound.
    Lara LS; Moreira CS; Calvet CM; Lechuga GC; Souza RS; Bourguignon SC; Ferreira VF; Rocha D; Pereira MCS
    Eur J Med Chem; 2018 Jan; 144():572-581. PubMed ID: 29289882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a novel β-lapachone derivative on Trypanosoma cruzi: Parasite death involving apoptosis, autophagy and necrosis.
    Dos Anjos DO; Sobral Alves ES; Gonçalves VT; Fontes SS; Nogueira ML; Suarez-Fontes AM; Neves da Costa JB; Rios-Santos F; Vannier-Santos MA
    Int J Parasitol Drugs Drug Resist; 2016 Dec; 6(3):207-219. PubMed ID: 27770751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mode of action of nifurtimox and N-oxide-containing heterocycles against Trypanosoma cruzi: is oxidative stress involved?
    Boiani M; Piacenza L; Hernández P; Boiani L; Cerecetto H; González M; Denicola A
    Biochem Pharmacol; 2010 Jun; 79(12):1736-45. PubMed ID: 20178775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2,3-diphenyl-1,4-naphthoquinone: a potential chemotherapeutic agent against Trypanosoma cruzi.
    Ramos EI; Garza KM; Krauth-Siegel RL; Bader J; Martinez LE; Maldonado RA
    J Parasitol; 2009 Apr; 95(2):461-6. PubMed ID: 18788881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo studies of the antiparasitic activity of sterol 14α-demethylase (CYP51) inhibitor VNI against drug-resistant strains of Trypanosoma cruzi.
    Soeiro Mde N; de Souza EM; da Silva CF; Batista Dda G; Batista MM; Pavão BP; Araújo JS; Aiub CA; da Silva PB; Lionel J; Britto C; Kim K; Sulikowski G; Hargrove TY; Waterman MR; Lepesheva GI
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4151-63. PubMed ID: 23774435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial disruption and DNA fragmentation in Trypanosoma cruzi induced by naphthoimidazoles synthesized from beta-lapachone.
    Menna-Barreto RF; Corrêa JR; Pinto AV; Soares MJ; de Castro SL
    Parasitol Res; 2007 Sep; 101(4):895-905. PubMed ID: 17546464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.